Endologix Announces First Patient Treated in Ventana(TM) U.S. Clinical Trial
Published date : 01 June 2014
Article date : 31 January 2012
Endologix announces the first patient enrollment in the Company\'s U.S. clinical trial to evaluate the Ventana Fenestrated Stent Graft System for the endovascular repair of juxtarenal and pararenal AAAs. The procedure was performed by Matthew Eagleton, MD (Cleveland Clinic Foundation, Department of Vascular Surgery). National Principal Investigator Daniel G. Clair, MD (Chairman, Department of Vascular Surgery, Cleveland Clinic Foundation) proctored the procedure.